Os dados são atualizados diariamente a partir das seguintes fontes:

Busque por termos

Selecione ao lado o filtro desejado:

Últimos registros

Abaixo os últimos 30 registros encontrados em nossa base de dados.

Digite um termo acima para filtrar sua busca na tabela abaixo.

Repositório Título Autores Data URL
biorxivTranscriptome data from human nasal epithelial cells infected by H3N2 influenza virus indicate early unbalanced ROS/RNA levels, temporarily increased aerobic fermentation linked to enhanced α-tubulin and rapid energy-dependent IRF9-marked immunizationJose Helio Costa, ...2021-10-20
biorxivMajor complex trait for early de novo programming 'CoV-MAC-TED' detected in human nasal epithelial cells infected by two SARS-CoV-2 variants is promising for designing therapeutic strategiesJose Helio Costa, ...2021-10-20
biorxivDiscovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin LIttipat Meewan, ...2021-10-20
biorxivRepurposed nystatin to inhibit SARS-CoV-2 and mutants in the GI tractEszter Virag, ...2021-10-20
biorxivNeutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of InfectionTakuya Tada, ...2021-10-20
biorxivPost-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell lineDaniela Niemeyer, ...2021-10-20
biorxivPreparation of ingestible antibodies to neutralize the binding of SarsCoV2 RBD (receptor binding domain) to human ACE2 ReceptorGopi Kadiyala, ...2021-10-20
biorxivIntensive Single Cell Analysis Reveals Immune Cell Diversity among Healthy IndividualsYukie Kashima, ...2021-10-20
biorxivOral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female MiceSteven David Brooks, ...2021-10-20
biorxivAn intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant viral replication in rhesus macaquesYongjun Sui, ...2021-10-20
medrxivA cohort of 222 anti-CD20 treated patients with multiple sclerosis followed through the COVID-19 pandemic: Attenuated humoral but robust cellular immune responses after vaccination and infectionTatjana Schwarz, ...2021-10-19
biorxivRapid and Effective Inactivation of SARS-CoV-2 by a Cationic Conjugated Oligomer with Visible Light: Studies of Antiviral Activity in Solutions and on SupportsKemal Kaya, ...2021-10-19
medrxivAdapting cleft care protocols in low- and middle-income countries during and after COVID-19: a process-driven review with recommendationsMatthew John Fell, ...2021-10-19
medrxivAccuracy of emergency medical service telephone triage of need for an ambulance response in suspected COVID-19: An observational cohort studyCarl Marincowitz, ...2021-10-19
arxivFully Three-dimensional Radial VisualizationYifan Zhu ;Fan Dai ;Ranjan Maitra 2021-10-19
arxivDigital transformation of droplet/aerosol infection risk assessment realized on "Fugaku" for the fight against COVID-19Kazuto Ando ;Rahul Bale ;ChungGang Li ;Satoshi Matsuoka ;Keiji Onishi ;Makoto Tsubokura 2021-10-19
biorxivSARS-COV-2 γ variant acquires spike P681H or P681R for improved viral fitnessXiang-Jiao Yang2021-10-19
biorxivSARS-COV-2 C.1.2 variant is highly mutated but may possess reduced affinity for ACE2 receptorXiang-Jiao Yang2021-10-19
biorxivBugSplit: highly accurate taxonomic binning of metagenomic assemblies enables genome-resolved metagenomicsInduja Chandrakumar, ...2021-10-19
medrxivThe effect of circulating zinc, selenium, copper and vitamin K1 on COVID-19 outcomes: a Mendelian randomization studyMaria K Sobczyk, ...2021-10-19
biorxivδ1 variant of SARS-COV-2 acquires spike V1176F and yields a highly mutated subvariant in EuropeXiang-Jiao Yang2021-10-19
medrxivImpact of SARS-CoV-2 infection on longitudinal vaccine immune responsesSebastian Havervall, ...2021-10-19
medrxivLack of Trust, Insufficient knowledge and Risk denial; an in-depth Understanding of Health worker Barriers to uptake of the Covid-19 vaccine at Iganga Hospital Eastern Uganda, and Mengo Hospital Kampala UgandaLubega Muhamadi, ...2021-10-19
medrxivShared Genomic Architectures of Covid-19 and Antisocial Behavior: Implications During PandemicsCharleen D. Adams, ...2021-10-19
biorxivPreclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody CocktailPavel A Nikitin, ...2021-10-19
medrxivElevated antibody titers in Abdala vaccinees evaluated by Elecsys(R) anti-SARS-CoV-2 S highly correlate with UMELISA SARS-CoV-2 ANTI RBD, ACE-2 binding inhibition and viral neutralization assays.Gilda Lemos-Perez, ...2021-10-19
medrxivConflicts of interest and physicians' attitudes towards hydroxychloroquine as a treatment against COVID-19: A replication and extension of Roussel & Raoult (2020)Louis Freget, ...2021-10-19
medrxivIncidence of SARS-CoV-2 infection in a cohort of workers from the University of PortoJoana Pinto Costa, ...2021-10-18
medrxivLong-term manifestations and modifiers of prevalence estimates of the post-COVID-19 syndrome: A systematic review and meta-analysis.Daniel De-la-Rosa-Martínez, ...2021-10-18
medrxivMolecular evidence of coinfection with acute respiratory viruses and high prevalence of SARS-CoV-2 among patients presenting flu-like illness in Bukavu city, Democratic Republic of CongoPatrick Ntagereka Bisimwa, ...2021-10-18
Acompanhe conosco outras fontes importantes sobre covid-19 do Brasil

Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Diariamente, o Ministério da Saúde, por meio da Secretaria de Vigilância em Saúde (SVS/MS) divulga dados consolidados sobre o COVID-19. Saiba mais sobre o painel.

Este projeto utiliza recursos computacionais e cientistas de dados da Plataforma de Ciência de Dados aplicada à Saúde do Laboratório de Informação em Saúde do Icict da Fiocruz (PCDaS), hospedada no Laboratório Nacional de Computação Científica (LNCC).

Campus Sede:

Av. Brasil, 4365 – Manguinhos, Rio de Janeiro – CEP: 21040-900 – Tel: (0xx21) 2598-4242

Este portal é regido pela Política de Acesso Aberto ao Conhecimento, que busca garantir à sociedade o acesso gratuito, público e aberto ao conteúdo integral de toda obra intelectual produzida pela Fiocruz.

© COPYRIGHT / Todos os direitos reservados ao Laboratório de Informação Científica e Tecnológica em Saúde – LICTS / FIOCRUZ